These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

180 related items for PubMed ID: 9136943

  • 1. Intermittent exposure to doxorubicin in vitro selects for multifactorial non-P-glycoprotein-associated multidrug resistance in RPMI 8226 human myeloma cells.
    Wyler B, Shao Y, Schneider E, Cianfriglia M, Scheper RJ, Frey BM, Gieseler F, Schmid L, Twentyman PR, Lehnert M.
    Br J Haematol; 1997 Apr; 97(1):65-75. PubMed ID: 9136943
    [Abstract] [Full Text] [Related]

  • 2. Idarubicin overcomes P-glycoprotein-related multidrug resistance: comparison with doxorubicin and daunorubicin in human multiple myeloma cell lines.
    Roovers DJ, van Vliet M, Bloem AC, Lokhorst HM.
    Leuk Res; 1999 Jun; 23(6):539-48. PubMed ID: 10374847
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Intrinsic resistance to chemotherapeutic agents in murine osteosarcoma cells.
    Takeshita H, Kusuzaki K, Ashihara T, Gebhardt MC, Mankin HJ, Hirasawa Y.
    J Bone Joint Surg Am; 2000 Jul; 82-A(7):963-9. PubMed ID: 10901311
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Decreased mutation rate for cellular resistance to doxorubicin and suppression of mdr1 gene activation by the cyclosporin PSC 833.
    Beketic-Oreskovic L, Durán GE, Chen KG, Dumontet C, Sikic BI.
    J Natl Cancer Inst; 1995 Nov 01; 87(21):1593-602. PubMed ID: 7563202
    [Abstract] [Full Text] [Related]

  • 10. Altered MRP is associated with multidrug resistance and reduced drug accumulation in human SW-1573 cells.
    Eijdems EW, Zaman GJ, de Haas M, Versantvoort CH, Flens MJ, Scheper RJ, Kamst E, Borst P, Baas F.
    Br J Cancer; 1995 Aug 01; 72(2):298-306. PubMed ID: 7640209
    [Abstract] [Full Text] [Related]

  • 11. Decreased drug accumulation without increased drug efflux in a novel MRP-overexpressing multidrug-resistant cell line.
    Gaj CL, Anyanwutaku I, Chang YH, Cheng YC.
    Biochem Pharmacol; 1998 Apr 15; 55(8):1199-211. PubMed ID: 9719474
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Characterisation of multidrug-resistant Ehrlich ascites tumour cells selected in vivo for resistance to etoposide.
    Nielsen D, Maare C, Eriksen J, Litman T, Friche E, Skovsgaard T.
    Biochem Pharmacol; 2000 Aug 01; 60(3):353-61. PubMed ID: 10856430
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. BIRICODAR (VX-710; Incel): an effective chemosensitizer in neuroblastoma.
    Yanagisawa T, Newman A, Coley H, Renshaw J, Pinkerton CR, Pritchard-Jones K.
    Br J Cancer; 1999 Jun 01; 80(8):1190-6. PubMed ID: 10376971
    [Abstract] [Full Text] [Related]

  • 18. Evidence for a constitutive, verapamil-sensitive, non-P-glycoprotein multidrug resistance phenotype in malignant glioma that is unaltered by radiochemotherapy in vivo.
    Rieger L, Rieger J, Winter S, Streffer J, Esser P, Dichgans J, Meyermann R, Weller M.
    Acta Neuropathol; 2000 May 01; 99(5):555-62. PubMed ID: 10805101
    [Abstract] [Full Text] [Related]

  • 19. Selection of non-P-glycoprotein mediated high-level etoposide resistant cell lines by adriamycin with P-gp inhibitors.
    Ades S, Maxfield LF, Gould CJ, Jones GK, Levy SB.
    Int J Oncol; 2006 Mar 01; 28(3):747-53. PubMed ID: 16465381
    [Abstract] [Full Text] [Related]

  • 20. Lack of elevated drug efflux in adriamycin-resistant immunoblastic B lymphoma cells with mdr1 overexpression.
    Chao CC.
    FEBS Lett; 1995 Oct 16; 373(3):285-90. PubMed ID: 7589484
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.